Clinical Trials Logo

Clinical Trial Summary

Aim of study: To compare the relationship between serum AMH and ovarian response for IVF with the GnRH antagonist protocol in patients who are carriers of FSH and/or LH receptor polymorphisms with those that are not.


Clinical Trial Description

Serum AMH has shown to have a high predictive capability of the ovarian response to stimulation for IVF. On the other hand, patients who are carriers of polymorphisms in the FSH and LH receptors, have shown to need higher doses of gonadotrophins for ovarian stimulation. The proportion of carriers has been described to be around 20% of the population. Nevertheless, the determination of these polymorphisms is not performed in routine practice. It is unknown if their presence affects to the relationship between serum AMH levels and ovarian response.

This is a prospective, single center, non-interventional, cohorts study. ;


Study Design


Related Conditions & MeSH terms

  • antimüllerian Hormone and Gonadotrophin Receptor Polymorphism as Predictors of Ovarian Response

NCT number NCT03388099
Study type Observational
Source Instituto Valenciano de Infertilidad, IVI VALENCIA
Contact
Status Completed
Phase
Start date January 11, 2018
Completion date December 18, 2019